Hepatitis C virus infection in ocular adnexal lymphomas

Archives of Ophthalmology

Volumn 128, Issue 10, 2010, Pages 1295-1299

  Strianese, Diego ^a   Tranfa, Fausto ^a   Finelli, Marialuisa ^a   De Renzo, Amalia ^a   Staibano, Stefania ^a   Schiemer, Roberta ^a   Cardone, Domenico ^a   Pacelli, Roberto ^a   Perna, Fabiana ^a   Mascolo, Massimo ^a   De Rosa, Gaetano ^a   Bonavolontà, Giulio ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; CYCLOPHOSPHAMIDE; DOXORUBICIN; PREDNISONE; RIBAVIRIN; RITUXIMAB; VINCRISTINE SULFATE; ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER REGRESSION; CANCER RELAPSE; COMPARATIVE STUDY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE FREE SURVIVAL; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; NONHODGKIN LYMPHOMA; OCULAR ADNEXAL NONHODGKIN LYMPHOMA; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEROPREVALENCE; CANCER STAGING; CONJUNCTIVAL NEOPLASMS; EYE INFECTIONS, VIRAL; EYE NEOPLASMS; EYELID NEOPLASMS; LACRIMAL APPARATUS DISEASES; LYMPHOMA, NON-HODGKIN; MIDDLE AGED; MORTALITY; ORBITAL NEOPLASMS; PATHOLOGY; PREVALENCE; RADIOTHERAPY; SURVIVAL RATE; VERY ELDERLY; VIROLOGY;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; CONJUNCTIVAL NEOPLASMS; DISEASE-FREE SURVIVAL; EYE INFECTIONS, VIRAL; EYE NEOPLASMS; EYELID NEOPLASMS; FEMALE; HEPATITIS C; HUMANS; LACRIMAL APPARATUS DISEASES; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; NEOPLASM STAGING; ORBITAL NEOPLASMS; PREVALENCE; RADIOTHERAPY; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 77957981147     PISSN: 00039950     EISSN: 15383601     Source Type: Journal    
DOI: 10.1001/archophthalmol.2010.233     Document Type: Article

References (26)

1. Saito I, Miyamura T, Ohbayashi A, et al. Hepatitis C virus infection is associated with the development of hepatocellular carcinoma. Proc Natl Acad Sci U S A. 1990;87(17):6547-6549. (Pubitemid 20351517)
2. King PD, Wilkes JD, Diaz-Arias AA. Hepatitis C virus infection in non-Hodgkin's lymphoma. Clin Lab Haematol. 1998;20(2):107-110.
3. Luppi M, Grazia Ferrari M, Bonaccorsi G, et al. Hepatitis C virus infection in subsets of neoplastic lymphoproliferations not associated with cryoglobulinemia. Leukemia. 1996;10(2):351-355.
4. Gisbert JP, García-Buey L, Pajares JM,Moreno-Otero R. Prevalence of hepatitis C virus infection in B-cell non-Hodgkin's lymphoma: systematic review and meta-analysis. Gastroenterology. 2003;125(6):1723-1732. (Pubitemid 37500437)
5. De Renzo A, Perna F, Persico M, et al. Excellent prognosis and prevalence of HCV infection of primary hepatic and splenic non-Hodgkin's lymphoma. Eur J Haematol. 2008;81(1):51-57.
6. Mele A, Pulsoni A, Bianco E, et al. Hepatitis C virus and B-cell non-Hodgkin lymphomas: an Italian multicenter case-control study. Blood. 2003;102(3):996-999.
7. Duberg A-S, Nordström M, Törner A, et al. Non-Hodgkin's lymphoma and other nonhepatic malignancies in Swedish patients with hepatitis C virus infection. Hepatology. 2005;41(3):652-659.
8. Takeshita M, Sakai H, Okamura S, et al. Prevalence of hepatitis C virus infection in cases of B-cell lymphoma in Japan. Histopathology. 2006;48(2):189-198.
9. Morgensztern D, Rosado M, Silva O, et al. Prevalence of hepatitis C infection in patients with non-Hodgkin's lymphoma in South Florida and review of the literature. Leuk Lymphoma. 2004;45(12):2459-2464. (Pubitemid 40081190)
10. Ferreri AJM, Viale E, Guidoboni M, et al. Clinical implications of hepatitis C virus infection in MALT-type lymphoma of the ocular adnexa. Ann Oncol. 2006;17(5):769-772.
11. Grünberger B, Wöhrer S, Streubel B, et al. Antibiotic treatment is not effective in patients infected with Helicobacter pylori suffering from extragastric MALT lymphoma. J Clin Oncol. 2006;24(9):1370-1375. (Pubitemid 46622000)
12. Gruenberger B, Woehrer S, Troch M, et al. Assessment of the role of hepatitis C, Helicobacter pylori and autoimmunity in MALT lymphoma of the ocular adnexa in 45 Austrian patients. Acta Oncol. 2008;47(3):355-359.
13. Arnaud P, Escande M-C, Lecuit M, et al. Hepatitis C virus infection and MALTtype ocular adnexal lymphoma. Ann Oncol. 2007;18(2):400-403.
14. Svoboda J, Andreadis C, Downs LH, Miller WT Jr, Tsai DE, Schuster SJ. Regression of advanced non-splenic marginal zone lymphoma after treatment of hepatitis C virus infection. Leuk Lymphoma. 2005;46(9):1365-1368. (Pubitemid 41269305)
15. Harris NL, Jaffe ES, Diebold J, et al. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997. J Clin Oncol. 1999;17(12):3835-3849.
16. Ishak K, Baptista A, Bianchi L, et al. Histological grading and staging of chronic hepatitis. J Hepatol. 1995;22(6):696-699.
17. Besson C, Canioni D, Lepage E, et al; Groupe d'Etude des Lymphomes de l'Adulte Programs. Characteristics and outcome of diffuse large B-cell lymphoma in hepatitis C virus-positive patients in LNH 93 and LNH 98 Groupe d'Etude des Lymphomes de l'Adulte programs. J Clin Oncol. 2006;24(6):953-960.
18. Verma V, Shen D, Sieving PC, Chan CC. The role of infectious agents in the etiology of ocular adnexal neoplasia. Surv Ophthalmol. 2008;53(4):312-331.
19. Ferreri AJM, Guidoboni M, Ponzoni M, et al. Evidence for an association between Chlamydia psittaci and ocular adnexal lymphomas. J Natl Cancer Inst. 2004; 96(8):586-594.
20. Chanudet E, Zhou Y, Bacon CM, et al. Chlamydia psittaci is variably associated with ocular adnexal MALT lymphoma in different geographical regions. J Pathol. 2006;209(3):344-351.
21. Machida K, Cheng KT-N, Sung VM-H, et al. Hepatitis C virus induces a mutator phenotype: enhanced mutations of immunoglobulin and protooncogenes. Proc Natl Acad Sci U S A. 2004;101(12):4262-4267. (Pubitemid 38405917)
22. (H)1-69 gene is preferentially used by hepatitis C virus-associated B cell lymphomas and by normal B cells responding to the E2 viral antigen. Blood. 2001;97(4):1023-1026.
23. Marasca R, Vaccari P, Luppi M, et al. Immunoglobulin gene mutations and frequent use of VH1-69 and VH4-34 segments in hepatitis C virus-positive and hepatitis C virus-negative nodal marginal zone B-cell lymphoma. Am J Pathol. 2001;159(1):253-261.
24. Hermine O, Lefrère F, Bronowicki JP, et al. Regression of splenic lymphoma with villous lymphocytes after treatment of hepatitis C virus infection. N Engl J Med. 2002;347(2):89-94. (Pubitemid 34753478)
25. La Mura V, De Renzo A, Perna F, et al. Antiviral therapy after complete response to chemotherapy could be efficacious in HCV-positive non-Hodgkin's lymphoma. J Hepatol. 2008;49(4):557-563.
26. Vallisa D, Bernuzzi P, Arcaini L, et al. Role of anti-hepatitis C virus (HCV) treatment in HCV-related, low-grade, B-cell, non-Hodgkin's lymphoma: a multicenter Italian experience. J Clin Oncol. 2005;23(3):468-473.